文献速递肺栓塞与肺血管病

使用一般人群生物样本库研究肺动脉高压的警告:以孟德尔随机化为重点

A cautionary note on the naive use of general-population biobanks to study pulmonary arterial hypertension, with a focus on Mendelian randomisation.
PubMed 文献 · Eur Respir J · 2025-10-16

本文指出使用一般人群生物样本库数据研究肺动脉高压(PAH)存在两个问题:统计效力低和非随机误分类,相较于金标准数据会导致假阳性和假阴性发现。文章以孟德尔随机化研究为重点发出警告。

要点

  • 一般人群生物样本库研究PAH存在统计效力低的问题
  • 非随机误分类会导致假阳性和假阴性结果
  • 应谨慎使用生物样本库数据进行PAH的孟德尔随机化研究

核心结论

  • 使用一般人群生物样本库数据研究PAH存在统计效力低和非随机误分类两个问题,会导致假阳性和假阴性发现。

主要发现

  • 与金标准数据相比,使用一般人群生物样本库数据研究PAH会导致假阳性和假阴性发现。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

There are two issues with using existing data from general-population biobanks to study PAH: low power and non-random misclassification. Relative to gold standard data, this results in false-positive and false-negative findings. https://bit.ly/4nksm6c Pulmonary hypertension (PH) is defined by a mean pulmonary artery pressure >20 mmHg [1]. Patients with PH are assigned to one of five internationally recognised groups. Pulmonary arterial hypertension (PAH), or group 1 PH, is a heterogeneous collection of conditions characterised by increased precapillary pulmonary vascular resistance. Groups 2 to 5 PH comprise PH caused, in turn, by left heart disease, lung diseases (e.g. COPD), chronic thromboembolism, and miscellaneous causes such as haematological diseases.

来源:Eur Respir J,查看原文。版权归原作者所有。

引用

  1. Woolf B, De Bie E, McLaughlin V, et al. A cautionary note on the naive use of general-population biobanks to study pulmonary arterial hypertension, with a focus on Mendelian randomisation. Eur Respir J. 2025. PMID: 40967765. doi:10.1183/13993003.00436-2025

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。